Supernormal Antithrombin Activity Is an Independent Predictor of In-Hospital Mortality in Patients With Sepsis: A Retrospective Observational Study

被引:5
作者
Azuhata, Takeo [1 ,2 ]
Hayakwa, Mineji [3 ]
Maekawa, Kunihiko [3 ]
Komatsu, Tomohide [1 ]
Kuwana, Tsukasa [1 ]
Kawano, Daisuke [1 ,2 ]
Nakamura, Kazuhiro [1 ,2 ]
Kinoshita, Kosaku [1 ]
Wada, Takeshi [3 ]
Tanjoh, Katsuhisa [1 ,2 ]
机构
[1] Nihon Univ, Sch Med, Dept Acute Med, Div Emergency & Crit Care Med, Tokyo, Japan
[2] Seitokai Azuhata Hosp, Dept Gen & Acute Med, Ibaraki, Japan
[3] Hokkaido Univ Hosp, Dept Emergency Med, Sapporo, Hokkaido, Japan
关键词
antithrombin; disseminated intravascular coagulation; mortality; prognosis; sepsis; DISSEMINATED INTRAVASCULAR COAGULATION; SEPTIC SHOCK; SUPPLEMENTATION;
D O I
10.1177/1076029620912827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Supernormal antithrombin (AT) activity is rare in patients with sepsis. This study compared mortality rate of patients with sepsis and supernormal AT activity with that of other patients. This retrospective study included patients with sepsis from 42 intensive care units (ICUs) in Japan. Patients were included if their AT activity was measured on ICU admission, and if they did not receive AT concentrate. They were categorized into low, normal, and supernormal with respective AT activity of <= 70%, >70% to <= 100%, and >100%. The primary outcome was hospital in-patient mortality. Nonlinear regression analysis showed that mortality risk gradually increased with AT activity in the supernormal range, but without statistical significance. Survival rate was significantly lower in low (67%) and supernormal (57%) AT groups than in the normal AT group (79%; P < .001 and P = .008, respectively). After adjusting for disease severity and AT activity on day 2, supernormal AT activity was the only independent predictor of mortality. Sepsis with supernormal AT activity associated with high mortality, independent of disease severity, might be a predictor of in-hospital mortality.
引用
收藏
页数:7
相关论文
共 21 条
[1]   Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation [J].
Aibiki, Mayuki ;
Fukuoka, Noriyasu ;
Umakoshi, Kensuke ;
Ohtsubo, Saori ;
Kikuchi, Satoshi .
SHOCK, 2007, 27 (02) :139-144
[2]   Severe Sepsis and Septic Shock REPLY [J].
Angus, Derek C. ;
van der Poll, Tom .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (21) :2063-2063
[3]   SEPTIC SHOCK, MULTIPLE ORGAN FAILURE, AND DISSEMINATED INTRAVASCULAR COAGULATION - COMPARED PATTERNS OF ANTITHROMBIN-III, PROTEIN-C, AND PROTEIN-S DEFICIENCIES [J].
FOURRIER, F ;
CHOPIN, C ;
GOUDEMAND, J ;
HENDRYCX, S ;
CARON, C ;
RIME, A ;
MAREY, A ;
LESTAVEL, P .
CHEST, 1992, 101 (03) :816-823
[4]  
Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1
[5]   THE RESPONSE OF ANTITHROMBIN III ACTIVITY AFTER SUPPLEMENTATION DECREASES IN PROPORTION TO THE SEVERITY OF SEPSIS AND LIVER DYSFUNCTION [J].
Hayakawa, Mineji ;
Sawamura, Atsushi ;
Yanagida, Yuichiro ;
Sugano, Masahiro ;
Hoshino, Hirokatsu ;
Gando, Satoshi .
SHOCK, 2008, 30 (06) :649-652
[6]   Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011-2013 [J].
Hayakawa, Mineji ;
Yamakawa, Kazuma ;
Saito, Shinjiro ;
Uchino, Shigehiko ;
Kudo, Daisuke ;
Iizuka, Yusuke ;
Sanui, Masamitsu ;
Takimoto, Kohei ;
Mayumi, Toshihiko .
SCIENTIFIC DATA, 2018, 5
[7]   Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study [J].
Hayakawa, Mineji ;
Yamakawa, Kazuma ;
Kudo, Daisuke ;
Ono, Kota .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (06) :874-883
[8]   ANTITHROMBIN SUPPLEMENTATION AND MORTALITY IN SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY [J].
Hayakawa, Mineji ;
Kudo, Daisuke ;
Saito, Shinjiro ;
Uchino, Shigehiko ;
Yamakawa, Kazuma ;
Iizuka, Yusuke ;
Sanui, Masamitsu ;
Takimoto, Kohei ;
Mayumi, Toshihiko ;
Ono, Kota ;
Azuhata, Takeo ;
Ito, Fumihito ;
Yoshihiro, Shodai ;
Hayakawa, Katsura ;
Nakashima, Tsuyoshi ;
Ogura, Takayuki ;
Noda, Eiichiro ;
Nakamura, Yoshihiko ;
Sekine, Ryosuke ;
Yoshikawa, Yoshiaki ;
Sekino, Motohiro ;
Ueno, Keiko ;
Okuda, Yuko ;
Watanabe, Masayuki ;
Tampo, Akihito ;
Saito, Nobuyuki ;
Kitai, Yuya ;
Takahashi, Hiroki ;
Kobayashi, Iwao ;
Kondo, Yutaka ;
Matsunaga, Wataru ;
Nachi, Sho ;
Miike, Toru ;
Takahashi, Hiroshi ;
Takauji, Shuhei ;
Umakoshi, Kensuke ;
Todaka, Takafumi ;
Kodaira, Hiroshi ;
Andoh, Kohkichi ;
Kasai, Takehiko ;
Iwashita, Yoshiaki ;
Arai, Hideaki ;
Murata, Masato ;
Yamane, Masahiro ;
Shiga, Kazuhiro ;
Hori, Naoto .
SHOCK, 2016, 46 (06) :623-631
[9]  
Hayakawa M, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0169-9
[10]   Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays [J].
Hillarp, A. ;
Baghaei, F. ;
Blixter, I. Fagerberg ;
Gustafsson, K. M. ;
Stigendal, L. ;
Sten-Linder, M. ;
Strandberg, K. ;
Lindahl, T. L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (01) :133-139